Publication
Intravenous versus subcutaneous Trastuzumab in the treatment of breast cancer
| dc.contributor.author | Maximiano, Sofia | |
| dc.contributor.author | Magalhães, Paulo | |
| dc.contributor.author | Guerreiro, Mara Pereira | |
| dc.contributor.author | Morgado, Manuel | |
| dc.date.accessioned | 2016-09-20T14:59:34Z | |
| dc.date.available | 2016-09-20T14:59:34Z | |
| dc.date.issued | 2015-10-28 | |
| dc.description | Poster presented at the 44th ESCP Symposium on Clinical Pharmacy. Lisbon, 28-30 October 2015 | pt_PT |
| dc.identifier.doi | 10.13140/rg.2.1.4921.0326 | |
| dc.identifier.uri | http://hdl.handle.net/10400.26/14767 | |
| dc.language.iso | eng | pt_PT |
| dc.subject | Trastuzumab | pt_PT |
| dc.subject | Breast cancer | pt_PT |
| dc.subject | Intravenous formulation | pt_PT |
| dc.subject | Subcutaneous formulation | pt_PT |
| dc.title | Intravenous versus subcutaneous Trastuzumab in the treatment of breast cancer | pt_PT |
| dc.type | conference object | |
| dspace.entity.type | Publication | |
| oaire.citation.conferencePlace | Lisboa | pt_PT |
| oaire.citation.title | 44th ESCP Symposium on Clinical Pharmacy | pt_PT |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | conferenceObject | pt_PT |